---
title: "Wedbush Remains a Buy on Arcus Biosciences (RCUS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295118153.md"
description: "Wedbush analyst Robert Driscoll reiterated a Buy rating on Arcus Biosciences (RCUS) with a $43 price target. This follows a Buy from H.C. Wainwright, while Wells Fargo assigned a Hold rating to the stock on the same day."
datetime: "2026-08-06T13:08:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295118153.md)
  - [en](https://longbridge.com/en/news/295118153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295118153.md)
generator: "portal-rs"
---

# Wedbush Remains a Buy on Arcus Biosciences (RCUS)

Wedbush analyst Robert Driscoll reiterated a Buy rating on Arcus Biosciences today and set a price target of $43.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Driscoll covers the Healthcare sector, focusing on stocks such as Kura Oncology, Replimune Group, and Revolution Medicines. According to TipRanks, Driscoll has an average return of 9.8% and a 44.94% success rate on recommended stocks. 

In addition to Wedbush, Arcus Biosciences also received a Buy from H.C. Wainwright’s Emily Bodnar in a report issued today. However, on the same day, Wells Fargo assigned a Hold rating to Arcus Biosciences (NYSE: RCUS).

### Related Stocks

- [RCUS.US](https://longbridge.com/en/quote/RCUS.US.md)
- [KURA.US](https://longbridge.com/en/quote/KURA.US.md)
- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)
- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Arcus Biosciences (RCUS) Stock Looks Strong On Returns But Stretched On Sales](https://longbridge.com/en/news/296529363.md)
- [Arcus Biosciences (RCUS) Reported Q2 2026 Results, Is The Stock A Bargain?](https://longbridge.com/en/news/295821029.md)
- [Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firm](https://longbridge.com/en/news/296412663.md)
- [Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)](https://longbridge.com/en/news/296510282.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**